Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lovastatin downregulates renal myofibroblast function in vitro.

Kristen J Kelynack1, Tim D Hewitson, Marina Martic

  • 1Department of Nephrology, Royal Melbourne Hospital, Parkville, Vic., Australia.

Nephron
|July 26, 2002
PubMed
Summary

Lovastatin, a cholesterol-lowering drug, was found to reduce kidney myofibroblast activity in laboratory studies. This suggests potential benefits for preventing kidney scarring by inhibiting myofibroblast proliferation and collagen production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emotional, behavioural and adaptive function in children with chronic kidney disease: the Kids with CKD (KCAD) study.

Pediatric nephrology (Berlin, Germany)·2025
Same author

A Within-Trial Economic Evaluation of a Patient Navigator Program in Children With CKD.

Kidney international reports·2025
Same author

Perspectives of Caregivers on Access to Health Care for Children with CKD.

Kidney international reports·2024
Same author

Longitudinal associations between socioeconomic position and overall health of children with chronic kidney disease and their carers.

Pediatric nephrology (Berlin, Germany)·2023
Same author

School attendance and sport participation amongst children with chronic kidney disease: a cross-sectional analysis from the Kids with CKD (KCAD) study.

Pediatric nephrology (Berlin, Germany)·2023
Same author

Propagation, Culture, and Characterization of Renal Fibroblasts.

Methods in molecular biology (Clifton, N.J.)·2023

Area of Science:

  • Nephrology
  • Cell Biology
  • Pharmacology

Background:

  • Interstitial fibrosis is a key indicator of progressive kidney disease.
  • Myofibroblasts drive fibrosis through proliferation, collagen synthesis, and matrix remodeling.
  • Statins may offer kidney protection beyond lipid reduction by targeting myofibroblasts.

Purpose of the Study:

  • To investigate the in vitro effects of lovastatin on rat renal myofibroblast behavior.
  • To assess lovastatin's impact on myofibroblast proliferation, collagen synthesis, and matrix contraction.

Main Methods:

  • Primary rat renal cortical myofibroblasts were cultured.
  • Cells were treated with varying doses of lovastatin (0, 15, 30 microM).
  • Effects on cell kinetics, collagen synthesis, collagen I lattice contraction, and actin rearrangement were measured.

Related Experiment Videos

Main Results:

  • Lovastatin significantly decreased myofibroblast proliferation and growth.
  • Collagen I lattice contraction and actin filament rearrangement were partially inhibited at 30 microM lovastatin.
  • Lovastatin reduced both collagen and collagenase synthesis by myofibroblasts.

Conclusions:

  • Lovastatin demonstrates potential to downregulate myofibroblast function in vitro.
  • Inhibiting myofibroblast activity with lovastatin may offer a therapeutic strategy for preventing progressive renal scarring.
  • Further research is needed to confirm the clinical significance of these findings.